Harel Insurance Investments & Financial Services Ltd. Scholar Rock Holding Corp Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Jan 29, 2019	SELL	$17.86 - $28.77 $148,309 - $238,906	-8,304 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$13.39 - $26.25 $111,190 - $217,980	8,304 New	8,304 $214,000

Others Institutions Holding SRRK

# of Institutions

175

Shares Held

75.6M

Call Options Held

585K

Put Options Held

862K

Siren, L.L.C. New York, NY

11.3M
Shares

$474 Million
4.51% of portfolio
Price T Rowe Associates Inc Baltimore, MD

8.65M
Shares

$364 Million
0.01% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

6.79M
Shares

$286 Million
31.52% of portfolio
Black Rock Inc. New York, NY

5.66M
Shares

$238 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

5.24M
Shares

$221 Million
2.74% of portfolio

View Full List

About Scholar Rock Holding Corp

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

More about SRRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account